MaxCyte to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024 and Participate in Upcoming Investor Conferences Feb 9, 2024 08:05AM
MaxCyte to Report Fourth Quarter and Full Year 2022 Financial Results on March 15, 2023 and Participate in Upcoming Investor Conferences Feb 1, 2023 04:05PM
MaxCyte to Participate in Upcoming Investor Conferences Feb 14, 2022 08:00AM
MaxCyte, Inc. (MXCT) Prices Upsized 13.5M Share Nasdaq IPO at $13/sh Jul 30, 2021 05:26AM
MaxCyte Announces Pricing of Upsized Offering and Approval to List on the Nasdaq Global Select Market Jul 29, 2021 10:42PM


Jul 26, 2021 07:49AM MaxCyte Announces Launch of Offering and Application to List on the Nasdaq Global Market
Jul 12, 2021 02:00AM MaxCyte Announces Public Filing of Registration Statement with SEC for a Proposed Nasdaq Dual Listing